The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review.

IF 3.5 3区 医学 Q1 SURGERY
BJS Open Pub Date : 2025-07-01 DOI:10.1093/bjsopen/zraf070
Giampaolo Perri, Jennie Engstrand, Robin D Wright, Sebastiaan F C Bronzwaer, Tiuri E Kroese, Biying Huang, Belkacem Acidi, Alessandro Vitale, Hop S Tran Cao, Richard van Hillegersberg, Magnus Nilsson, Ernesto Sparrelid, Matthew H G Katz, Giovanni Marchegiani, Umberto Cillo
{"title":"The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers: comprehensive review.","authors":"Giampaolo Perri, Jennie Engstrand, Robin D Wright, Sebastiaan F C Bronzwaer, Tiuri E Kroese, Biying Huang, Belkacem Acidi, Alessandro Vitale, Hop S Tran Cao, Richard van Hillegersberg, Magnus Nilsson, Ernesto Sparrelid, Matthew H G Katz, Giovanni Marchegiani, Umberto Cillo","doi":"10.1093/bjsopen/zraf070","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In the absence of a commonly accepted definition, conversion surgery is generally considered as surgical resection with the intent of prolonging survival after non-surgical induction therapy in patients with upfront unresectable disease at diagnosis. Despite the heterogeneity of possible targets, conversion surgery is a quickly evolving concept, with commonalities for upper gastrointestinal (UGI) and hepato-pancreato-biliary (HPB) malignancies.</p><p><strong>Methods: </strong>A comprehensive narrative review of the most recent and relevant literature was conducted by experts in the field of different UGI and HPB tumours.</p><p><strong>Results: </strong>The increased interest of the surgical scientific community in the concept of conversion surgery can be explained by the continuous improvements in non-surgical therapies aimed at controlling the systemic tumour burden and the local extension of cancer, supported by improvements in surgical outcomes for advanced resections in expert centres. The toolbox of the surgical oncologist seeking conversion in the case of unresectable UGI and HBP tumours is large and includes (but is not limited to) systemic chemotherapy, (chemo)radiation, targeted therapy/immunotherapy, locoregional ablation techniques, intra-arterial therapies, liver hypertrophy induction techniques, treatments of underlying medical conditions, and prehabilitation.</p><p><strong>Conclusions: </strong>Conversion surgery represents a powerful instrument to prolong the survival of patients with unresectable UGI and HPB malignancies. However, most of the available evidence is of a low level and at very high risk of selection bias. Alongside a profound understanding of (and respect for) the biology of cancer, which remains key to selecting appropriate patients and avoiding non-therapeutic surgeries, a commonly accepted definition is urgently needed to standardize practice, monitor outcomes, and improve the quality of research.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"9 4","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12238947/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJS Open","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/bjsopen/zraf070","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In the absence of a commonly accepted definition, conversion surgery is generally considered as surgical resection with the intent of prolonging survival after non-surgical induction therapy in patients with upfront unresectable disease at diagnosis. Despite the heterogeneity of possible targets, conversion surgery is a quickly evolving concept, with commonalities for upper gastrointestinal (UGI) and hepato-pancreato-biliary (HPB) malignancies.

Methods: A comprehensive narrative review of the most recent and relevant literature was conducted by experts in the field of different UGI and HPB tumours.

Results: The increased interest of the surgical scientific community in the concept of conversion surgery can be explained by the continuous improvements in non-surgical therapies aimed at controlling the systemic tumour burden and the local extension of cancer, supported by improvements in surgical outcomes for advanced resections in expert centres. The toolbox of the surgical oncologist seeking conversion in the case of unresectable UGI and HBP tumours is large and includes (but is not limited to) systemic chemotherapy, (chemo)radiation, targeted therapy/immunotherapy, locoregional ablation techniques, intra-arterial therapies, liver hypertrophy induction techniques, treatments of underlying medical conditions, and prehabilitation.

Conclusions: Conversion surgery represents a powerful instrument to prolong the survival of patients with unresectable UGI and HPB malignancies. However, most of the available evidence is of a low level and at very high risk of selection bias. Alongside a profound understanding of (and respect for) the biology of cancer, which remains key to selecting appropriate patients and avoiding non-therapeutic surgeries, a commonly accepted definition is urgently needed to standardize practice, monitor outcomes, and improve the quality of research.

前段不可切除的上消化道和肝-胰-胆道癌的转换手术概念的演变:全面回顾。
背景:在缺乏一个普遍接受的定义的情况下,转换手术通常被认为是在诊断为前期不可切除疾病的患者进行非手术诱导治疗后延长生存期的手术切除。尽管可能的靶点存在异质性,但转换手术是一个快速发展的概念,在上胃肠道(UGI)和肝-胰-胆(HPB)恶性肿瘤中具有共性。方法:由不同UGI和HPB肿瘤领域的专家对最新的相关文献进行全面的叙述回顾。结果:外科科学界对转换手术概念的兴趣日益增加,可以通过旨在控制全身肿瘤负担和癌症局部扩展的非手术治疗的不断改进来解释,并得到专家中心高级切除手术结果的改善的支持。在无法切除的UGI和HBP肿瘤病例中,外科肿瘤学家寻求转化的工具箱很大,包括(但不限于)全身化疗、(化疗)放疗、靶向治疗/免疫治疗、局部消融技术、动脉内治疗、肝肥厚诱导技术、潜在疾病治疗和康复治疗。结论:转换手术是延长无法切除的UGI和HPB恶性肿瘤患者生存的有力手段。然而,大多数可获得的证据都是低水平的,而且存在非常高的选择偏倚风险。除了对癌症生物学的深刻理解(和尊重),这仍然是选择合适的患者和避免非治疗性手术的关键,迫切需要一个普遍接受的定义来规范实践,监测结果,提高研究质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BJS Open
BJS Open SURGERY-
CiteScore
6.00
自引率
3.20%
发文量
144
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信